Format

Send to

Choose Destination
Stem Cells Dev. 2013 Dec;22 Suppl 1:25-8. doi: 10.1089/scd.2013.0402.

Somatic cell nuclear transfer in Oregon: expanding the pluripotent space and informing research ethics.

Author information

1
California Institute of Regenerative Medicine , San Francisco, California.

Abstract

In May, Oregon Health and Science University (OHSU) announced the successful derivation, by the Mitalipov laboratory, of embryonic stem cells by somatic cell nuclear transfer. This experiment was recognized as a "formidable technical feat" and potentially a key step toward developing cell-based therapies. The OHSU report is also an example of how a scientific breakthrough can inform research ethics. This article suggests ways that nuclear transfer embryonic stem cell lines may contribute to research ethics by adding rigor to studies addressing pressing research questions important to the development of cell-based therapies.

PMID:
24304071
DOI:
10.1089/scd.2013.0402
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center